Mirada Medical launches Caseaccess PET-CT image management software

23 June 2010

Mirada Medical Limited has launched Caseaccess, a software package that provides remote access to PET-CT and SPECT-CT scans and reports.

 It combines the company's fusion image analysis software with online image visualisation technologies to provide remote access to PET-CT and SPECT-CT scans and reports via fast, richly featured multi-modal quantitative imaging software.

Mirada Medical aims to provide readers with greater clinical certainty in the diagnosis and treatment of disease by providing enhanced 3D multi-modal imaging together with powerful quantification tools that can be used to assess how pathology, for example malignant tumours, are responding to treatment regimes.

Mirada’s products were launched into the global marketplace in 2001 and are currently sold through leading international imaging companies including Siemens, Sectra, Carestream, Vital Images and McKesson.

The company’s technology was founded by one of the world’s leading imaging scientists, Professor Sir Michael Brady, at Oxford University’s Medical Vision Laboratory centre.

Caseaccess is Mirada’s third product to be launched into the global marketplace in the last 12 months. It allows efficient dissemination of patient imaging information and reporting via sophisticated technology that takes image data from the centre where the patient was scanned and makes this available to the referring physician regardless of where the referrer is located.

This provides significant technological advantages over currently available report distribution mechanisms. These often use slow and unreliable methods, such as posting a CD containing the image data and report, or relaying patient information via inefficient web based packages and tools that prevent the referring physician from being able to fully and clearly understand the patient’s condition.

Chief Technology Officer, Dr Timor Kadir said: “The purpose of healthcare IT is to increase workflow efficiency while assisting clinical users to obtain the best possible quality of information from the raw data. Both imaging centres and referrers will benefit from Mirada’s new Caseaccess product. Caseaccess reliably and rapidly disseminates all of the available data and information which has been acquired, certainly boosting productivity and enabling an improved level of communication and understanding, particularly for the referring physician.”

Hugh Bettesworth, CEO of Mirada Medical, added: “We are delighted to be launching another new product that supports decision makers and the ongoing management of complex disease such as cancer. Mirada continues to be clinically and commercially focused and aims to deliver better healthcare solutions in the critical field of cancer imaging. We are penetrating new markets internationally and enjoying a growing presence in our key US market.”

To top